Visiogen Overview

  • Year Founded
  • 2001

Year Founded

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $400M

Visiogen General Information

Description

Developer of products for cataract and refractive patients. The company offers an accommodating intraocular lens, which provides distance, intermediate, and near vision to presbyopic cataract patients.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • Two Goodyear
  • Suite B
  • Irvine, CA 92618
  • United States
+1 (949)
Primary Industry
Therapeutic Devices
Acquirer
Corporate Office
  • Two Goodyear
  • Suite B
  • Irvine, CA 92618
  • United States
+1 (949)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Visiogen Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
8. Merger/Acquisition 20-Oct-2009 $400M Completed Generating Revenue
7. Later Stage VC (Series E) 27-Apr-2009 Completed Generating Revenue
6. Later Stage VC (Series D) 28-Feb-2007 Completed Generating Revenue
5. Later Stage VC (Series C2) 03-Feb-2005 Completed Generating Revenue
4. Later Stage VC (Series C) 02-Dec-2003 Completed Generating Revenue
3. Early Stage VC (Series B2) 25-Jun-2002 Completed Generating Revenue
2. Early Stage VC (Series B1) 21-Jun-2001 $4.09M $4.39M Completed Generating Revenue
1. Early Stage VC (Series A) $300K $300K Completed
To view Visiogen’s complete valuation and funding history, request access »

Visiogen Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series E
Series D
Series C2
Series C
Series B2
Series B1 3,407,036 $0.000100 $0.1 $1.2 $1.2 1x $1.2 7.69%
Series A 1,000,000 $0.000100 $0.02 $0.3 $0.3 1x $0.3 2.26%
To view Visiogen’s complete cap table history, request access »

Visiogen Former Investors (10)

Investor Name Investor Type Holding Investor Since Participating Rounds
DLJ Capital Group Venture Capital Minority
Foundation Medical Partners Corporate Venture Capital Minority
New Leaf Venture Venture Capital Minority
Novartis Venture Fund Corporate Venture Capital Minority
Pinnacle Ventures Venture Capital Minority
You’re viewing 5 of 10 investors. Get the full list »

Visiogen FAQs

  • When was Visiogen founded?

    Visiogen was founded in 2001.

  • Where is Visiogen headquartered?

    Visiogen is headquartered in Irvine, CA.

  • What industry is Visiogen in?

    Visiogen’s primary industry is Therapeutic Devices.

  • Is Visiogen a private or public company?

    Visiogen is a Private company.

  • What is the current valuation of Visiogen?

    The current valuation of Visiogen is .

  • What is Visiogen’s current revenue?

    The current revenue for Visiogen is .

  • How much funding has Visiogen raised over time?

    Visiogen has raised $90.1M.

  • Who are Visiogen’s investors?

    DLJ Capital Group, Foundation Medical Partners, New Leaf Venture, Novartis Venture Fund, and Pinnacle Ventures are 5 of 10 investors who have invested in Visiogen.

  • When was Visiogen acquired?

    Visiogen was acquired on 20-Oct-2009.

  • Who acquired Visiogen?

    Visiogen was acquired by Abbott.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process